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Molecular dynamicsHelix–helix interactions in the putative three-helix bundle formation of the gp41 transmembrane (TM)
domain may contribute to the process of virus–cell membrane fusion in HIV-1 infection. In this study,
molecular dynamics is used to analyze and compare the conformations of monomeric and trimeric forms of
the TM domain in various solvent systems over the course of 4 to 23-ns simulations. The trimeric bundles of
the TM domain were stable as helices and remained associated in a hydrated POPE lipid bilayer for the
duration of the 23-ns simulation. Several stable inter-chain hydrogen bonds, mostly among the three
deprotonated arginine residues located at the center of each of the three TM domains, formed in a right-
handed bundle embedded in the lipid bilayer. No such bonds were observed when the bundle was left-
handed or when the central arginine residue in each of the three TM helices was replaced with isoleucine
(R_I mutant), suggesting that the central arginine residues may play an essential role in maintaining the
integrity of the three-helix bundle. These observations suggest that formation of the three-helix bundle of
the TM domain may play a role in the trimerization of gp41, thought to occur during the virus–cell membrane
fusion process.© 2009 Elsevier B.V. All rights reserved.1. IntroductionExtensive studies of the human immunodeﬁciency virus type 1
(HIV-1) over the past two decades have given us a great deal of
information regarding the function of each of its viral components and
themechanismof cell infection in causing disease [1]. HIV-1 consists of
one RNA and 15 proteins. Among these proteins, two envelope
glycoproteins, gp120 and gp41, produced from proteolytic cleavage
of a precursor peptide, gp160 [2], are responsible for initiating cell
infection. It is widely accepted that binding of the surface envelope
protein (gp120) of themature virion to receptors of the cell is followed
by subsequent virus–cell membrane fusion by the transmembrane
envelope protein (gp41), leading to entry of the core into the cell [3–5].
The three-dimensional structure of the entire gp41 molecule (345
amino acids) is unknown, but the envelope glycoprotein is generally
believed to be a trimeric complex, with its six individual subunits
(three gp120 and three gp41 subunits) held together by noncovalent
interactions [6–8]. Two crystal structures of a small core fragment of
the gp41 protein have been reported [9,10]. The core region is a six-
helix bundle consisting of the interior parallel coiled-coil trimer of
N36 and the exterior antiparallel C34, which is similar to the low-pH
induced conformation of inﬂuenza hemagglutinin; thus, the core
region is probably not the resting structure of gp41 but rather a
structure formed during the fusion reaction. Proposed models for cell
fusion by gp41 have so far been based on the structure of the core+1 256 372 8288.
ll rights reserved.region [3,4], andmost current studies of gp41 in the cell fusion process
are focused on it. In conﬁrmation of the proposed models, small
peptides similar in structure to C34 or N36 of the core region have
been found to inhibit the fusion process. A new generation of anti-HIV
drugs based on this information is in clinical trials by pharmaceutical
companies [11,12].
Two signiﬁcant regions of gp41 are not included in the core region:
an N-terminal hydrophobic glycine-rich “fusion” peptide (FP), which
is believed to initiate fusion, and the transmembrane (TM) domain,
which has an important role in anchoring the envelope proteins in the
viral membrane and in fusion [13]. Recently, the structure of the gp41
fusion peptide has been studied by using molecular dynamics
simulations [14] and by spectroscopic and electron microscopic
methods [15–17]. Since TM domains are essential components of
structural integrity for many membrane proteins [18], it is interesting
to consider whether the TM domain of gp41 may be involved in
oligomerization of the protein in the native environment. Mutation
studies suggest that the gp41 TM domain is important for the
membrane fusion process [19], and the gp41 TM region is thought to
play an important role in anchoring the envelope proteins in the viral
membrane during HIV-cell fusion [13]. Our TOXCAT (a measure of
transmembrane helix association in a biological membrane [20])
study using the 22 amino acid-TM domain (685IFIMIVGGLVGLRIV-
FAVLSIV706) of gp41 (and its mutated fragments) from HIV-1 ARV2/
SF2 isolate suggests that the TM domain associates (see Results and
discussion).
Despite its possible role in the structure and function of gp41, the
difﬁculty of studying it has resulted in little attention being paid to the
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(the core region). Insights on the structure of the TM domain and its
self-associationwould be useful in understanding how the TM domain
contributes to the overall oligomeric conformation of gp41 and to the
virus–cell membrane fusion process.
It has been difﬁcult to obtain atomic-level structures of single TM
integral membrane proteins because these proteins do not crystallize
well. However, computational methods have proven to be very useful
for investigation of the TM domains of membrane proteins, and have
been successful in suggesting structures that later proved correct
(e.g., glycophorin [21,22]). In this paper, we report a molecular
dynamics (MD) study of monomers and possible three-helix bundles
of the gp41 TM domain in a hydrated lipid bilayer and other solvent
systems. Stability in different environments and the structures of the
bundles are studied in order to better understand gp41 TM domain
oligomerization.
2. Materials and methods
2.1. TOXCAT
TOXCAT constructs consist of an N-terminal DNA-binding domain of
ToxR, a transmembrane domain, and the periplasmic maltose-binding
protein. ToxR′(gp41-TM)MBP chimerae contained the complete TM
domain, with the amino sequence of 685IFIMIVGGLVGLRIVFAVLSIV706.
Individual constructs were cloned by mutating the wild-type gp41
construct using the QuikChange site-directed mutagenesis kit
(Stratagene) protocol using oligonucleotides ∼20 base pairs long.
Constructs were transformed into Escherichia coli NT326 (MalE-)
cells. Wholecell lysates were used to estimate expression levels of
the constructs. Samples were run on SDS-PAGE, and then Western
analysis was carried out using antibodies against MBP (NEB). Blots
were developed using goat anti-rabbit alkaline phosphatase sec-
ondary antibody (Pierce). The presence of MBP in the periplasm was
conﬁrmed by growth on minimal maltose media.
2.1.1. CAT assays
Cell-free extracts were made by pelleting 200 μl of cells at an A600
of 0.6, resuspending in 500 μl of 0.1 M Tris, pH 8.0, then lysing with
20 μl of 100 mM EDTA, 100 mM dithiothreitol, and 50 mM Tris, pH 8.0,
and one drop of toluene, at 30 °C for 30 min. The cell-free extract was
then diluted 1:80 before being used in the CAT assays. Brieﬂy, samples
were incubated at 37 °C with tritiated chloramphenicol and n-butyryl
coenzyme A. After 90 min, the reaction was halted by partitioning the
[3H]chloramphenicol–butyryl CoA complex into xylene. The organic
phase was washed and quantiﬁed using the radiolabel. All measure-
ments were performed four times. Errors shown are standard
deviations on four measurements.
2.2. Determination of the initial structures
The 20-residue TM domain (1FIMIVGGLVGLRIVFAVLSI20) of gp41
from the HIV-1 ARV2/SF2 isolate was used in the study. Starting
structures for trimeric helix bundles of gp41 TMdomains in vacuowere
determined at the Center for Structural Biology Computation Lab at
Yale using a global searching program, CHI (CNS Searching of Helix
Interactions [21]), whichutilizes themolecular dynamics programCNS
(Crystallography and NMR system [23]) with the OPLS force ﬁeld
(optimized potentials for liquid simulations, Jorgensen and Tirado-
Rives [24]). This method has proven to be successful in predicting the
structures of transmembrane proteins [25,26]. Three parallelα-helices
were positioned with the distance between centers of neighboring
helices set at 0.4 Å and an initial crossing angle at 25°. A set of
structureswas obtained by rotating the helices from0° to 360° for each
starting structure (both left-handed and right-handed) using a 45°
step size. For each structure, four trials were run using simulatedannealing of all atomic coordinates, with rotation and crossing angles
free to vary (36×4×2=288 structures for symmetric searches, where
the helices were rotated cooperatively to preserve a threefold axis;
8×8×8×4×2=4096 structures for full searches without the three-
fold constraint on the starting structures). Root mean square
deviations (RMSDs) of atomic coordinates between structures were
then determined to select clusters of similar structures, thought to
represent basins of convergence. An average structure for each cluster
and the spread of structures in each cluster were found, and the
interaction energy between residues of the averaged structure for each
cluster was calculated. Structures with high interaction energy and
large contact areawere chosen as starting structures for themolecular
dynamics simulations.
2.3. Molecular dynamics
Molecular dynamics simulations of gp41 TM single-helix strands
and trimeric helix bundles were performed using the MPI version of
GROMACS 3.2.1 [27] running on the Cray XD1 at the Alabama
Supercomputer Center in Huntsville, AL (typically running in parallel
on 4 Opteron processors). For a single-helix strand or a helix bundle
embedded in a hydrated lipid bilayer, the helix (bundle) was inserted
in a hydrated 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidyletha-
nolamine (POPE) lipid bilayer (using the topology and structure for
the lipid bilayer from Tieleman and Berendsen [28]). The single helix
(or the helix bundle) was placed on the lipid bilayer by generating a
box of the solvent, namely the hydrated POPE, around the helix (or the
helix bundle). The helix (or the helix bundle) was inserted in the
center of the box in a perpendicular orientation to the lipid bilayer
plane. Solvent (lipid and water) molecules were removed from the
box when the distance between any atom of the helix (or the helix
bundle) and any atom of the solventmoleculewas less than the sum of
the van der Waals radii of both atoms. After energy minimization, the
system was equilibrated for an extended period of time by using
position-restrained molecular dynamics (with the positions of the
helix bundle restrained but the positions of others free to move) until
the density (or volume), pressure, and temperature became stabilized
(typically for about 3 ns). Na+ and Cl− ions were included tomaintain
the neutral charge of the system and a physiological salt concentration
of 0.154 M. The sodium and chloride ions replaced water molecules at
the position of the ﬁrst atoms with the most favorable electrostatic
potential. In order to simulate the physiological salt concentration of
0.154 M, about one NaCl pair for every 360 water molecules or one
ion per 180 water molecules was added. Since between 4000 and
6000 water molecules were typically used in each system, between
11 and 17 NaCl pairs (11–17 Na+ and 11–17 Cl−) were added. (Salt
ions were added to water only, not to the lipid bilayer.) The density of
the system was around 1.02 g/ml while the pressure and the
temperature were maintained at 1.0 bar and 300 K, respectively. Full
molecular dynamics was carried out using a periodic boundary
condition and the isothermal-isobaric (NPT) ensemble with a time
step of 1 fs (300 K, 1 bar, Nosé–Hoover temperature coupling [29,30]
with a time constant of 0.5 ps for each of the ﬁve groups, helix, lipid,
water, Na+, and Cl−, and Parinello–Rahman anisotropic pressure
coupling [31,32] with a coupling constant of 6.0 ps for each of the 6
components). Long-range interactions were treated with the parti-
cle-mesh Ewald method (PME [33]; interpolation order of 4 with a
grid spacing of 0.12 nm) and the SPC model was used for water
molecules [34].
3. Results and discussion
3.1. TOXCAT study
The level of association in the TOXCAT assay (as measured by
expression of CAT) of the gp41 construct is lower than that of
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G83I control as seen in Fig. 1. Uponmutation of two glycine residues in
the TM domain to isoleucine (G691 and G695, or residues numbers 6
and 10 in our model for the MD study), the level association decreases
slightly. This is likely attributable to the role of the two glycine
residues in the inter-chain interaction in association of the gp41 TM
domains. Upon replacement of the arginine-697 residue (the
arginine-12 residue in our model) with isoleucine, there is a similar
decrease in association, implying the role of the arginine residue in
oligomerization of the gp41 TM domains. Although the TOXCAT study
is inconclusive as to the position of the interface, it is certain that the
constructs do oligomerize in TOXCAT.
3.2. Stability of the monomeric helix of the TM domain in lipid and
in water
The MD simulations of the single chain 20-residue TM domain
(1FIMIVGGLVGLRIVFAVLSI20) were carried out in aqueous solution
and in the hydrated lipid bilayer in order to examine helix stability in
different environments. First, RMSDs of the Cα atoms from the initial
structure over time were compared. As can be seen in Fig. 2a, the Cα
RMSDs rise almost continuously to reach around 0.6 nm at the end of
the 4-ns simulation for the structure in aqueous solution, implying
that the structure drifts away continuously from the starting helical
structure. However, in a 4 ns simulation, the Cα RMSDs ﬂuctuate no
more than 0.1 nm in the lipid bilayer, suggesting that the structure
stays very close to the original helical structure in this environment.
In order to examine the ﬂuctuations in structure, the residue-by-
residue root mean square ﬂuctuation (RMSF) of the Cα atoms from
their average positions for the duration of the simulation was
examined. Fig. 2b shows that the Cα RMSF values are signiﬁcantly
higher in water than in the lipid bilayer: among the non-terminal
residues, Leu-8 and Val-9 have particularly large RMSFs in water. As
can be seen in the ﬁgure, the Cα RMSF vs. the residue number in the
lipid bilayer shows a relatively ﬂat line, with even the Cα RMSF values
of the terminal residues falling below 0.1 nm. The Cα RMSF
comparison suggests that the TM helix is unstable in water but very
stable in the lipid environment. Other helical parameters, such as the
helix radius, rise per residue, and twist per residue seen over the ﬁrst
4-ns of theMD simulation (Fig. 2c–e) also show that the conformation
of the TM domain undergoes a signiﬁcant change in water, especially
during the ﬁrst 2 ns. However, these parameters show marked
stability in the lipid bilayer (throughout the total 12 ns of simulation,
although only the ﬁrst 4 ns are shown in the ﬁgure). Loss of α-helicityFig.1. CAT levels normalized to thewild-type of glycophorin A (GpA). G83I is the dimer-
disruptive mutant of glycophorin A. Gp41 wt shows signiﬁcant CAT levels, implying the
gp41 TM domains oligomerize. Upon changing the interfacial arginine residue to
isoleucine residue, the CAT levels decrease.in water is evident in the ﬁrst 6–7 residues of the amino terminus
(and, to a much lesser degree, in the carboxyl terminus). This can be
seen from the sudden decrease in the twist angle of the helix at
around 2 ns of the simulation period, as shown in Fig. 2e. Simulations
using a 28-residue sequence containing the TM domain (YIKIFI-
MIVGGLVGLRIVFAVLSIVNRV) produce similar results. (Cα RMSD
versus time for the 28-residue monomeric helix of gp41 TM domain
in lipid is shown in Fig 2a.)
3.3. Conformational stability of the three-helix bundle
Conformational stabilities of helix bundles consisting of three 20-
residue TM domains (1FIMIVGGLVGLRIVFAVLSI20) were also exam-
ined in various environments: in a hydrated lipid bilayer, in DMSO, in
decane, and in water, using 5–23 ns MD simulations. The Cα RMSD vs.
time and Cα RMSF analyses (Fig. 3a, b) show that by far the smallest
deviations in Cα positions and RMS ﬂuctuations are observed in the
lipid bilayer, suggesting stability of the Cα positions in the helix
bundle. The RMSD values in the lipid bilayer, less than 0.2 nm at the
end of the 5-ns simulation, are as small as those observed in other
peptide simulations in lipid bilayer environments. These include MD
studies of the OmpF porin trimer [28], where the X-ray structure was
used as the starting structure, and MD studies of the Inﬂuenza A M2
Channel [35], where the starting structure was obtained by MD/
simulated annealing in vacuo. The RMSF is signiﬁcantly larger in
decane than in the other solvent systems, implying a very unstable
conformation of the helix bundle in decane. The fact that the helix
bundle shows higher stability in the lipid bilayer than in decane or
DMSO suggests that the interactions between some residues in the TM
domain and the POPE lipid molecules stabilize the bundle. Based on
helical parameters computed in the course of the simulation period
(e.g., the helix radius, rise per residue, and twist per residue), each of
the three-helix chains in the bundle appears to retain an α-helical
conformation in the lipid bilayer during the entire simulation period,
which is also supported by Ramachandran plot analysis (not shown).
In order to examinewhich handedness of the three-helix bundle is
favored, MD simulations of right- and left-handed bundles (with each
chain being right-handed α-helical) were carried out in the hydrated
lipid bilayer. Fig. 3c and d show the Cα RMSD and the Cα RMSF plots for
the right-handed and the left-handed three-helix bundles. Our data
suggest that the right-handed bundle has smaller RMS ﬂuctuations
than the left-handed helix bundles (0.188±0.028 versus 0.213
±0.022 nm). Unsurprisingly, the terminal residues of each helix
exhibit larger RMS ﬂuctuations for both the right- and the left-handed
helix bundles. These larger ﬂuctuations are probably due to the larger
number of possible interactions of the terminal residues with water
molecules and lipid head groups [35], and the lack of constraint from
the parts of the structure that are not represented in the model.
Analyses of the helical parameters (data not shown) suggest that the
TM domains in left-handed helix bundle also remain α-helical in the
course of the simulation periods. Thus, the data suggest that both the
right- and left-handed helix bundles appear to be stable in the lipid
bilayer for the simulation time frame used in the current study (18 to
23 ns), with the left-handed bundle somewhat less stable.
The secondary structures of the right- and left-handed three-helix
bundles of the TM domains were compared using the ϕ and ψ angles
for each of the 18 residues in each helical chain (a total of 54 residues
in the helix bundle). There appear to be no signiﬁcant differences in
these angles between the right- and left-handed bundles for the
duration of the simulation time frames used in the current study.
There is, however, a signiﬁcant difference in terms of inter-chain
hydrogen bonding between the right- and left-handed bundles. No
stable inter-chain hydrogen bonds are observed in the left-handed
helix bundle: only a few transient hydrogen bonds appear in the
course of the 18-ns simulation. In the right-handed bundle, on the
other hand, at least several stable inter-chain hydrogen bonds are
Fig. 2. (a) CαRMSD versus time for the 20-residuemonomeric helixof gp41 TMdomain in lipid (thick solid) and inwater (dashed). Cα RMSD versus time for the 28-residuemonomeric
helix of gp41 TM domain in lipid (dotted) virtually overlapswith the 20-residuemonomeric helix (thick solid). (b) Cα RMSFs for the samemodel in lipid (solid) and inwater (dotted).
Helix radius (c), rise per residue (d), and twist per residue (e) versus time for the 20-residue monomeric helix of gp41 TM domain in lipid (solid) and in water (dotted).
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able helical stability during the simulation time frame of 18 ns, the
three helical chains might not be able to maintain a stable helix
bundle in this fashion over an extended time frame in the absence of
stable hydrogen bonds among the three chains. (In our simulations in
vacuo, the right-handed helix bundle maintained its stability for the
entire duration of the 50-ns simulation, but the left-handed helix
bundle did not.) Further, conserved amino acids are involved in thehydrogen bonds. Therefore, we conjecture that the three gp41-
molecules associate through formation of the right-handed three-
helix bundle of the TM domains during cell–virus membrane fusion.
3.4. Inter-chain hydrogen bonds in the right-handed three-helix bundle
Based on the deﬁnition of Ravishanker et al. [36], the conformation
of the right-handed bundle in the lipid bilayer allows several stable
Fig. 4. Several inter-chain bond distances during the ﬁrst 5 ns of simulation of the
three-helix bundle of gp41 TM domains in lipid. Different hydrogen bonds are shown:
the hydrogen bond between Argn12 (Cζ) of Helix I and the hydrogen of Argn12 (Nɛ) of
Helix III (solid); between the hydrogen of Argn12 (NH1) of Helix I and Argn12 (NH1) of
Helix III (dotted); between Argn12 (NH1) of Helix I and the hydrogen of Argn12 (Nɛ) of
Helix III (dashed); between Argn12 (NH1) of Helix I and the hydrogen of Argn12 (NH1)
of Helix III (dot-dashed); and between Argn12 (NH2) of Helix I and the hydrogen of
Argn12 (Nɛ) of Helix III (dot-dash-dashed).
Fig. 3. Cα RMSD versus time (a) and Cα RMSFs (b) for the three-helix bundle of gp41 TM domains in lipid (solid), in DMSO (dotted), in decane (dashed), and inwater (dot-dashed). Cα
RMSD versus time (c) and Cα RMSFs (d) for right-(solid) and left-handed (dotted) three-helix bundle of gp41 TM domains in lipid.
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simulation, these hydrogen bonds remain stable throughout the entire
simulation period of 23 ns, as shown in Fig. 4. Most of these inter-chain
hydrogen bonds form among the deprotonated arginine-12 (denoted
Argn-12) residues located near the middle of each of the three helices
(Table 1). While the Argn-12 residues for each of the three helices in
the left-handed bundle are on the opposite side of the interface, these
arginine residues are at the interface in the right-handed helix
bundles. Therefore, these arginine residues may be essential in
formation of inter-chain hydrogen bonds in the three-helix bundle.
These inter-chain hydrogen bonds could play a major role in
maintaining the integrity of the helix bundle over a longer time scale.
3.5. Bundle with protonated central arginine residues
Arginine residues of a protein are typically protonated in aqueous
solution at physiological pH (the pKR of free arginine is 12.5). Since it
is of interest to see whether the central arginine residues in the three
TM domains can be protonated in the helix bundle, the helical stability
of the bundle with protonated arginine-12 (Arg-12) residues was
examined with a 10-ns simulation for each of the right- and the left-
handed bundles. Our MD studies show that the Cα RMSD values (Fig.
5a) of the bundle with the Arg-12 residues are larger than those for
the bundlewith the Argn-12 residues, and the RMSD values of the left-
handed bundles are larger than those of the right-handed bundles,
Table 1
Stable inter-chain hydrogen bonds in the right-handed three-helix bundle of the 20-
residue TM domain of gp41 fromHIV-1 observed during the course of 13-ns simulations
(after the 5-ns initial equilibration period).
Hydrogen
bond
Distance (Å) Angle (°) Distance (Å) Angle (°)
2nd 13 ns 2nd 13 ns 3rd 5 ns 3rd 5 ns
H bond 1 2.10±0.61 150.8±16.9 2.00±0.35 150.0±15.3
H bond 2 2.37±0.69 131.9±22.0 2.22±0.31 137.2±10.8
H bond 3 2.42±0.56 141.9±16.9 2.21±0.24 151.2±15.0
H bond 4 2.41±0.49 118.2±23.0 2.28±0.35 123.4±16.5
H bond 5 2.78±0.39 127.2±19.2 2.61±0.31 142.0±19.1
H bond 1: Argn12 (NH1) of Helix I-H······Argn12 (NH1) of Helix III
H bond 2: Argn12 (NH1) of Helix I······H-Argn12 (Nɛ) of Helix III
H bond 3: Argn12 (Cζ) of Helix I ······H-Argn12 (Nɛ) of Helix III
H bond 4: Argn12 (NH2) of Helix I······H-Argn12 (Nɛ) of Helix III
H bond 5: Phe15 (Cβ) of Helix I ······H-Argn12 (NH1) of Helix II
The bond distance is the X···H distance in angstroms (Å) shown as mean±standard
deviation,whereX is the hydrogen bond acceptor. The bond angle is theX···H-Yangle in
degrees shown as mean±standard deviation, where X is the hydrogen bond acceptor
and Y is the hydrogen bond donor. The criteria for deﬁning a hydrogen bond are an
average distance of X···H less than 2.8 Å and an average angle of X···H-Y greater than
120°, where X is the hydrogen bond acceptor [36]. The ﬁrst 5 ns of the simulation is an
equilibration phase, where the distances are very large at the beginning and gradually
decrease to form the hydrogen bonds. Therefore, the mean distances have no meaning.
Argn denotes deprotonated arginine.
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(The averaged RMSD values for the right- and the left-handed bundles
during the initial 5 ns are 0.250±0.432 and 0.318±0.044 nm for theFig. 5. Cα RMSD versus time (a) and Cα RMSFs (b) for right-(solid) and left-handed (dotted) t
domains in lipid. Cα RMSD versus time (c) and Cα RMSFs (d) for right-(solid) and left-handbundles with protonated arginine-12, and 0.188±0.028 and 0.213±
0.022 nm for bundles with deprotonated arginine-12, respectively.)
The Cα RMSF (Fig. 5b) also increases, especially in the terminal
residues, upon protonation of the arginine-12 residues. Although no
signiﬁcant differences can be observed for helical properties in terms
of helix radius, rise per residue, and twist per residue, there are larger
ﬂuctuations in these helical parameters in the bundle with the Arg-12
residues, suggesting a lower helical stability of the bundle upon
protonation of these arginine residues. The Ramachandran plot shows
that some residues have larger ψ angles (non-α-helical) in compar-
ison to the bundle with the Argn-12 residues. As the simulation
progresses, there appears to be a population increase of the residues
exhibiting the larger ψ angles, which are similar to those found in β-
strands. This aspect of conformation, i.e., increase of ψ angles in many
residues, resembles the bundle conformation with Argn-12 residues
observed in non-lipid environments, such as water, decane, and
DMSO. These observations suggest that the helix bundle with the
deprotonated arginine-12 residues is more stable and therefore ismore
likely to be a bundle in the three-helix formation of gp41.
3.6. Bundle with central arginine residues replaced with isoleucine
residues (R_I mutant)
In order to determine the role of the Argn-12 residues in bundle
formation, a new helical bundlewas created inwhich each of the three
arginine residues was replaced by isoleucine residues (denoted the
R_I mutant) using the procedure described in Materials and methods.hree-helix bundle of gp41 of wild-typewith the protonated central arginine residues TM
ed (dotted) three-helix bundle of gp41 of the R_I mutant TM domains in lipid.
Table 2
The lengths of the helices and the three-helix bundle, and the tilt angles of the helices and the bundle normal to the lipid bilayer, in the course of MD simulations.
Helix Wild type (RH) Wild type (LH) R_I (RH)
Simulation 23 ns 18 ns 15 ns
Length (nm) Tilt (°) Length (nm) Tilt (°) Length (nm) Tilt (°)
Chain 1 2.87±0.04 10.7±4.5 2.90±0.05 19.5±2.9 2.93±0.10 16.9±3.1
Chain 2 2.83±0.06 12.3±2.7 2.99±0.06 18.4±3.6 2.80±0.05 12.1±3.2
Chain 3 2.71±0.05 15.3±4.8 2.87±0.07 30.0±3.7 2.79±0.05 7.6±3.7
Bundle 2.77±0.04 9.9±3.4 2.71±0.04 7.0±3.2 2.79±0.03 3.9±2.4
Helix R_I (LH) Wild type, arg12 (RH) Wild type, arg12 (LH)
Simulation 15 ns 13 ns 10 ns
Length (nm) Tilt (°) Length (nm) Tilt (°) Length (nm) Tilt (°)
Chain 1 3.01±0.08 20.7±2.6 2.60±0.11 25.3±4.3 2.92±0.09 17.6±6.9
Chain 2 2.85±0.06 9.6±3.0 2.82±0.06 21.9±5.6 3.02±0.07 18.5±3.4
Chain 3 2.88±0.08 17.1±3.3 2.81±0.10 17.2±3.9 2.71±0.08 45.9±5.5
Bundle 2.80±0.04 5.2±2.6 2.56±0.06 6.4±2.9 2.54±0.08 9.8±2.6
The values are shown as mean±standard deviation.
Fig. 6. Snapshot of right-handed three-helix bundle viewed from top. Three
deprotonated arginine (Argn) residues from the three helical chains are interacting
with one another at the interfaces of the bundle.
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and left-handed) were simulated for 15 ns. The helix bundle of the R_I
mutants in water (both right- and left-handed) were simulated for
5 ns. The Cα RMSDs (Fig. 5c) are larger for the left-handed bundle than
for the right-handed bundle (0.200±0.026 versus 0.125±0.015 nm
during the initial 5-ns), and the Cα RMSF plots (Fig. 5d) for both the
right- and left-handed bundles of the R_I mutant are similar to those
of the wild-type bundles, with larger ﬂuctuations on the helical
termini. Although the Ramachandran plot of the right-handed bundle
of R_I is similar to that of the wild type counterpart, some residues
have larger ψ values. In addition, residues in the left-handed bundle of
the R_I mutant show awider range of ϕ angles. Based on the Cα RMSD,
Cα RMSF, and Ramachandran plots, the right-handed bundle of R_I
appears to be rather more stable and to maintain more α-helical
characteristics than the left-handed counterpart, but appears less
stable than the wild type.
In water, the conformations of the helix bundles (especially the
left-handed) of the R_I mutant are unstable, as expected. While the
right-handed bundle shows a Cα RMSD of ∼0.4 nm and a Cα RMSF of
between 0.15 and 0.4 nm (except for the Phe-1 residue of Chain 3,
which ﬂuctuates up to 0.8 nm), the left-handed bundle is extremely
unstable in water, with Cα RMSD reaching 2 nm and the Cα RMSF
ranging between 1.1 and 1.8 nm.While the Ramachandran plots of the
R_I bundles are similar to the wild-type bundles in water, some
residues exhibit larger ψ angles with β-strand characters.
No stable inter-chain hydrogen bonds were observed, however, in
the three-helix bundle (either right- or left-handed) of the R_I mutant
in the lipid bilayer during the course of 15 ns simulations. As discussed
previously, at least several stable inter-chain hydrogen bonds were
observed in the right-handed helix bundle of the wild-type TM
domains. The fact that no stable inter-chain hydrogen bonds could be
formed when the three Argn-12 residues in the bundle were replaced
with the isoleucine residues emphasizes that these arginine residues
may play an essential role in formation of the inter-chain hydrogen
bonds in the bundle, thereby maintaining the integrity of the three-
helix bundle of the gp41 TM domains.
3.7. Lengths and tilts of the helices and bundles
The average values of the lengths and tilts of the helices and the
bundles during the entire simulation periods of the three-helix
bundles for the wild-type (both with deprotonated and protonated
arginine residues) and the R_I mutant were calculated and are shown
in Table 2. The tilt and the length of each of these helices and bundles
ﬂuctuate around the average values listed in the table during the
entire period of the simulations; no differences in these values have
been observed during the initial few ns of the simulations. The right-handed helix bundle of the wild-type TM domains is slightly tilted
with respect to the lipid bilayer normal, with a tilt angle of 9.9±3.4°.
There are no signiﬁcant differences in these tilt angles among the
various helix bundles, varying between 3 and 10°. The extent of the tilt
angles of the individual helical chains in a bundle can give information
regarding the degree of interactions among the chains. The tilt angles
of the individual helical chains for the right-handed bundle of the
wild-type TM domains with respect to the lipid bilayer normal are
somewhat smaller than those in the left-handed bundle of the wild-
type TM domains or those in the helix bundles (both right- and left-
handed) where the arginine residues in all the three chains are
replaced with isoleucine residues. The tilt angles of the individual
helical strands seem to become considerably larger for the helix
bundles when the Argn-12 residues are protonated (for both right-
and left-handed helix bundles): larger crossing angles among the
helical strands in these bundles result in considerably shorter bundle
lengths (around 2.55 nm compared to 2.7–2.8 nm for other helix
bundles), as can be seen in Table 2. It appears that the inter-chain
interactions in the bundlewith protonated arginine residues gradually
diminish as the simulation progresses, leading to an increase in the
crossing angles and decrease in bundle lengths. Fig. 6 shows that three
1811J.H. Kim et al. / Biochimica et Biophysica Acta 1788 (2009) 1804–1812deprotonated arginine residues from each of the three helical chains
are interacting with one another at the interfaces of the bundle.
3.8. Stability comparison of various helix bundles
In order to compare the stability of the various helix bundles
discussed above, the potential energy for each of the following six
types of three-helix bundleswas calculated: the right- and left-handed
wild-type helix bundles with deprotonated arginine (Argn-12)
residues, the right- and left-handed wild-type helix bundles with
protonated arginine (Arg-12) residues, and the right- and left-handed
helix bundles in which arginine residues were replaced by isoleucine
residues (R_I). The structures of these helix bundles were obtained
from at least 10-ns simulations in the hydrated lipid bilayer. The
potential energy was calculated for each helix bundle alone, by
removing water, lipids, and ions from the system. Our data show that
the right-handed bundle is always more stable than its left-handed
counterpart for each type. In addition, the R_Imutant helix bundles are
signiﬁcantly less stable than the wild-type helix bundles (by about
360 kcal/mol), verifying the importance of the central arginine residue
in the TM domain for stability of the helix bundle formation.
The data also show that the helix bundles with Argn-12 are
considerably more stable than the helix bundles with Arg-12 (by at
least 230 kcal/mol), suggesting that the central arginine residues are
deprotonated in thehelix bundle. The gp41 TMdomain consists of all the
amino acids of non-polar side chains except for the arginine residue,
which is located in the middle of the TM domain. Considering the non-
polar environment of the lipid bilayer, the arginine residue should favor
the deprotonated (neutral) side chain. The signiﬁcance of the deproto-
nated arginine residue, however, appears to be its essential role in
formation of the three-helix bundle. Only the right-handed helix bundle
appears to allow the inter-chain hydrogen bonds among these three
Argn-12 residues, which stabilize the helix bundle, as veriﬁed by
potential energy comparison. As amatter of fact, the right-handedwild-
type helix bundlewith Argn-12 is the only helix bundle that stays intact
over a prolonged simulation: while all other helix bundles undergo
signiﬁcant deformation in various ways, the right-handed wild-type
helix bundle with Argn-12 maintains its stability for the entire duration
of the 50-ns simulation via its inter-chain hydrogen bonds.
4. Conclusions
Based on molecular dynamics simulations, the helical conforma-
tion of the gp41 TM domain appears to be stable in a hydrated lipid
bilayer. Inwater, however, the simulated helix forms a kink around the
Gly-7 residue, which leads to unwinding of the helix at the ﬁrst several
residues of the amino terminus.
The three-helix bundle of the HIV-1 gp41 TMdomains showsmuch
greater stability in the lipid bilayer than in other environments. Several
stable inter-chain hydrogen bonds were observed in the right-handed
helix bundle during the course of simulations, but no such bonds were
observed in the left-handed helix bundle. Most of the stable inter-
chain hydrogen bonds observed were formed among the three
conserved deprotonated arginine residues, each located in the middle
of the three TM domains. Therefore, the helix bundle is believed to be
right-handed during three-helix formation of HIV-1 gp41. Upon
protonation of the central arginine residues, the helix bundle became
unstable. When these arginine residues were replaced by three
isoleucine residues, no such inter-chain hydrogen bonding was
observed, suggesting that these arginine residues may play important
roles in maintaining the stability of the helix bundle. TOXCAT data
clearly show that the constructs do oligomerize, suggesting the
importance of oligomerization of the TM domain. In light of the fact
that stable inter-chain hydrogen bonds formwithin ∼1 ns and remain
stable throughout the entire period of the 23-ns simulations, it is very
likely that formation of the right-handed three-helix bundle of the TMdomain occurs (and perhaps is essential) in the formation of gp41
trimers, thought to occur during the virus–cell membrane fusion
process.
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